Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 31, 2017 - Issue 18
408
Views
21
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of the anticoagulant potential of polysaccharide-rich fractions extracted from macroalgaeFootnote

, , , & ORCID Icon
Pages 2126-2136 | Received 16 Sep 2016, Accepted 19 Dec 2016, Published online: 01 Feb 2017
 

Abstract

The aim of this study was to evaluate the potential anticoagulant activity of sulphated polysaccharide-containing extracts of six french edible marine macroalgae. Aqueous extracts of brown (Himanthalia elongata, Laminaria digitata, Ascophyllum nodosum, Fucus vesiculosus), green (Ulva lactuca) and red (Chondrus crispus) macroalgae were prepared and their biochemical properties were determined, including major biomolecules, sulphate and ash contents. The anticoagulant activity of each extract was investigated using different scales from the specific antithrombin-dependent pathway (anti-Xa and anti-IIa) to the intrinsic and/or common (Activated Partial Thromboplastin Time, APTT), extrinsic (Prothrombin Time, PT) or common (Thrombin Time, TT) anticoagulant pathways, and compared with those of commercial anticoagulants, heparin and Lovenox®. Laminaria digitata, Fucus vesiculosus and Chondrus crispus extracts showed a significant APTT anticoagulant capacity, only 5-fold lower than that of Lovenox®, which is a pure low molecular weight heparin used as an anticoagulant agent to prevent pulmonary embolism in patients undergoing surgery.

Acknowledgements:

We are very grateful to the hospital of La Rochelle, which kindly provided us Lovenox®, and to the “Biomolecule High Resolution Analysis Platform” from the LIENSs Laboratory of La Rochelle University for the UHPLC-HRMS analyses.

Notes

Presented to CIPAM 2016, 6th International Congress of Aromatic and Medicinal Plants, 29 May–1 June 2016, Coimbra (Portugal)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.